Welcome to our dedicated page for Raytech Holding SEC filings (Ticker: RAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Raytech Holding's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Raytech Holding's regulatory disclosures and financial reporting.
Raytech Holding Limited (Nasdaq: RAY) has filed a Rule 424(b)(4) prospectus for a best-efforts public offering of 25,985,000 ordinary shares at US$0.20 per share, potentially raising gross proceeds of US$5.20 million and net proceeds (before expenses) of US$4.83 million. Post-offering, total shares outstanding will rise to 43,598,083. CEO & Chairman Mr. Ching Tim Hoi will retain 12.8 million shares (29.4% voting power), ending Raytech’s previous “controlled company” status under Nasdaq rules.
Business model. Through wholly-owned Hong Kong subsidiary Pure Beauty, Raytech designs, sources and wholesales personal-care electrical appliances (hair dryers, straighteners, trimmers, etc.) for international brand owners. Hair-styling products contributed 48% of FY-2024 revenue; Koizumi Seiki Corp. alone accounted for 74% of FY-2024 sales, indicating material customer concentration. Manufacturing is almost entirely outsourced to two mainland-China factories—one (Zhongshan Raytech) is controlled by the CEO and supplied 88.5% of FY-2024 production.
Recent developments. • Auditor change (WWC, P.C. dismissed; Assentsure PAC appointed) effective April 9 2025.
• Board refresh: resignation of independent director Mr. Yiu Wing Hei; appointment of Mr. Li Shihua (May 19 2025) as independent director & audit-committee chair.
Regulatory landscape. Operations are in Hong Kong; Raytech has no PRC subsidiaries or VIE structure and believes—per PRC and Hong Kong counsel—that no CAC/CSRC approvals are currently required. Nonetheless, management highlights potential PRC “long-arm” intervention, national-security considerations, CSRC filing uncertainties and HFCA/AHFCAA delisting risk should PCAOB access change. Auditor WWC is U.S.-based and currently inspected by PCAOB.
Use of proceeds. According to the prospectus (p. 59), roughly 20% will fund international marketing (U.S., EU, Asia), 30% will expand headcount (sales, R&D, admin), and the balance will support working capital and product-line expansion (men’s grooming, oral care).
Key investment considerations
- Small capital raise (≈US$5 m) but highly dilutive—share count increases 148% versus pre-offering.
- High customer (Koizumi) and supplier (Zhongshan Raytech) concentration exposes earnings to single-counterparty risk.
- Regulatory uncertainty in Hong Kong/Mainland-China relations and potential HFCA compliance issues may weigh on valuation.
- Positive tailwinds from global personal-care appliance growth (forecast 5.5–7% CAGR) and Raytech’s 11-year operating history with established Japanese customer base.